Cargando…
Scaffold Hopping Toward Agomelatine: Novel 3, 4-Dihydroisoquinoline Compounds as Potential Antidepressant Agents
A scaffold-hopping strategy toward Agomelatine based on in silico screening and knowledge analysis was employed to design novel antidepressant agents. A series of 3, 4-dihydroisoquinoline compounds were selected for chemical synthesis and biological assessment. Three compounds (6a-1, 6a-2, 6a-9) dem...
Autores principales: | Yang, Yang, Ang, Wei, Long, Haiyue, Chang, Ying, Li, Zicheng, Zhou, Liangxue, Yang, Tao, Deng, Yong, Luo, Youfu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048153/ https://www.ncbi.nlm.nih.gov/pubmed/27698414 http://dx.doi.org/10.1038/srep34711 |
Ejemplares similares
-
Agomelatine: A novel melatonergic antidepressant
por: Manikandan, S
Publicado: (2010) -
The emergence of new antidepressants for clinical use: Agomelatine paradox versus other novel agents
por: Fasipe, Olumuyiwa John
Publicado: (2019) -
Potentiation of Antidepressant Effects of Agomelatine and Bupropion by Hesperidin in Mice
por: Nadar, Jegan Sakthivel, et al.
Publicado: (2018) -
Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
por: Taylor, David, et al.
Publicado: (2014) -
Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
Publicado: (2014)